IN2014CN03364A - - Google Patents
Download PDFInfo
- Publication number
- IN2014CN03364A IN2014CN03364A IN3364CHN2014A IN2014CN03364A IN 2014CN03364 A IN2014CN03364 A IN 2014CN03364A IN 3364CHN2014 A IN3364CHN2014 A IN 3364CHN2014A IN 2014CN03364 A IN2014CN03364 A IN 2014CN03364A
- Authority
- IN
- India
- Prior art keywords
- nanoparticles
- cell epitopes
- oligomerization domains
- peptide
- norovirus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11184906 | 2011-10-12 | ||
PCT/EP2012/069684 WO2013053642A1 (en) | 2011-10-12 | 2012-10-05 | Self-assembling peptide nanoparticles as vaccines against infection with norovirus |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014CN03364A true IN2014CN03364A (ja) | 2015-09-04 |
Family
ID=47010584
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN3364CHN2014 IN2014CN03364A (ja) | 2011-10-12 | 2012-10-05 |
Country Status (9)
Country | Link |
---|---|
US (1) | US20140242104A1 (ja) |
EP (1) | EP2766386A1 (ja) |
JP (1) | JP2014530224A (ja) |
CN (1) | CN104136454A (ja) |
AU (1) | AU2012323189A1 (ja) |
CA (1) | CA2851917A1 (ja) |
IN (1) | IN2014CN03364A (ja) |
RU (1) | RU2014106936A (ja) |
WO (1) | WO2013053642A1 (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106021974B (zh) * | 2016-05-19 | 2019-05-03 | 中牧智合(北京)生物技术有限公司 | 对t细胞表位进行优化的方法及由此制备的肽文库的组合物 |
EP3600402A1 (en) * | 2017-03-23 | 2020-02-05 | Alpha-O Peptides AG | Self-assembling protein nanoparticles with built-in six-helix bundle proteins |
WO2019241483A1 (en) * | 2018-06-13 | 2019-12-19 | The Scripps Research Institute | Nanoparticle vaccines with novel structural components |
EP3964532A4 (en) * | 2019-04-29 | 2023-06-07 | Academy of Military Medical Sciences | FUSION PROTEIN SELF-ASSEMBLING INTO PROTEIN NANOPARTICLES AND USE THEREOF |
WO2022106860A1 (en) * | 2020-11-20 | 2022-05-27 | Pécsi Tudományegyetem | Recombinant peptides for use in therapy |
JPWO2022149609A1 (ja) * | 2021-01-07 | 2022-07-14 | ||
CN113354716B (zh) * | 2021-08-11 | 2021-11-02 | 北京溯本源和生物科技有限公司 | 一种鼠诺如病毒重组抗原、单克隆抗体和病毒检测试纸条 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2581394B1 (fr) | 1985-05-02 | 1988-08-05 | Grp Genie Genetique | Particules ayant les proprietes immunogenes de l'antigene hbs et portant un site antigenique etranger aux epitopes portes par l'antigene hbs, vecteurs et cellules animales pour la production de telles particules et compositions contenant de telles particules pour la production de vaccins mixtes |
ATE415173T1 (de) | 1993-09-14 | 2008-12-15 | Pharmexa Inc | Pan dr-bindeproteinen zur erhöhung der immunantwort |
JP4085231B2 (ja) | 2000-02-28 | 2008-05-14 | 株式会社ビークル | タンパク質中空ナノ粒子とそれを用いた物質運搬体、ならびに細胞への物質導入方法 |
JP4509999B2 (ja) | 2003-02-17 | 2010-07-21 | ブルクハルト,ペーター | 医薬送達及び抗原提示システムとしてのペプチドナノ粒子 |
CN104740624B (zh) * | 2007-09-18 | 2018-04-24 | 武田疫苗股份有限公司 | 赋予针对诺如病毒的保护性免疫应答的疫苗 |
WO2009109428A2 (en) | 2008-02-01 | 2009-09-11 | Alpha-O Peptides Ag | Self-assembling peptide nanoparticles useful as vaccines |
DE602008004898D1 (de) * | 2008-06-27 | 2011-03-24 | Theranor Sprl | Pharmazeutische Zusammensetzungen von Antikörpern von Viruserkrankungen |
-
2012
- 2012-10-05 JP JP2014535012A patent/JP2014530224A/ja active Pending
- 2012-10-05 WO PCT/EP2012/069684 patent/WO2013053642A1/en active Application Filing
- 2012-10-05 CA CA 2851917 patent/CA2851917A1/en not_active Abandoned
- 2012-10-05 AU AU2012323189A patent/AU2012323189A1/en not_active Abandoned
- 2012-10-05 US US14/350,426 patent/US20140242104A1/en not_active Abandoned
- 2012-10-05 RU RU2014106936/04A patent/RU2014106936A/ru not_active Application Discontinuation
- 2012-10-05 EP EP12770477.3A patent/EP2766386A1/en not_active Withdrawn
- 2012-10-05 CN CN201280061311.8A patent/CN104136454A/zh active Pending
- 2012-10-05 IN IN3364CHN2014 patent/IN2014CN03364A/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20140242104A1 (en) | 2014-08-28 |
WO2013053642A1 (en) | 2013-04-18 |
EP2766386A1 (en) | 2014-08-20 |
AU2012323189A1 (en) | 2014-03-06 |
RU2014106936A (ru) | 2015-11-20 |
JP2014530224A (ja) | 2014-11-17 |
CA2851917A1 (en) | 2013-04-18 |
CN104136454A (zh) | 2014-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014CN03364A (ja) | ||
CY1122278T1 (el) | Αντι il-36r αντισωματα | |
CY1121392T1 (el) | Μορια δεσμευσης εναντι-αλφα συνουκλεϊνης | |
CY1120398T1 (el) | Ανθρωποποιημενα αντισωματα που αναγνωριζουν αλφα-συνουκλεϊνη | |
DK2728002T3 (da) | Heterodimeriseret polypeptid | |
CY1118906T1 (el) | Χαμηλης συγγενειας αντισωματα υποδοχεα αιματοεγκεφαλικου φραγμου και χρησεις αυτων | |
MX2015006548A (es) | Proteinas vinculantes que comprenden al menos dos dominios de repeticion contra her2. | |
CY1119567T1 (el) | Θεραπευτικα πεπτιδια | |
DK2940135T5 (da) | Heterodimeriseret polypeptid | |
HK1224178A1 (zh) | 環肽作為蛋白質靶向劑 | |
CY1116842T1 (el) | Ειδικα εξανθρωπισμενα αντισωματα στην πρωτοϊνιδιακη μορφη του βητα-αμυλοειδους πεπτιδιου | |
WO2012031250A3 (en) | Compositions for labeling nerves and methods of use | |
DK2797616T3 (da) | Celle-penetrerende peptider | |
BR112014017749A2 (pt) | Composto alquinilbenzeno 3,5-dissubstituído e sal do mesmo | |
WO2009109428A3 (en) | Self-assembling peptide nanoparticles useful as vaccines | |
EP3082797A4 (en) | Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof | |
CY1118885T1 (el) | Συνθετικες πεπτιδογλυκανες που δεσμευουν υαλουρονικο οξυ, παρασκευη, και μεθοδοι χρησης | |
MX355268B (es) | Anticuerpos de peptido beta amiloide anti-n3pglu y usos de los mismos. | |
UY34608A (es) | Péptidos sintéticos de tránsito al cloroplasto. | |
JP2014518898A5 (ja) | ||
EA201390074A1 (ru) | 5-хлор-4-гидрокси-1-метил-2-оксо-n-фенил-1,2-дигидрохинолин-3-карбоксамид, его соли и применения | |
EA201490778A1 (ru) | АНТИТЕЛА ПРОТИВ HtrA1 И СПОСОБЫ ПРИМЕНЕНИЯ | |
UA118167C2 (uk) | Пептид та його застосування | |
BR112013030824A2 (pt) | bactéria gram-positiva, ácido necleico recombinante, composição farmacêutica e vetor | |
UA106900C2 (uk) | Агоністичний dr5-зв'язувальний поліпептид |